Insights into the role of the gut microbiome in metabolic syndrome

  • A. Kakimova Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • S. Kozhakhmetov Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • A. Kazhybayev Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • G. Mukasheva Eurasian National University named after L.N. Gumilyev
  • S. Saduakhassova Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • Zh. Khassenbekova Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • M. Urasova Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • A. Kushugulova Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University
  • T. Nurgozhin Human Microbiome Laboratory, Center for Life Sciences, Nazarbayev University

Abstract

Metabolic syndrome is a worldwide epidemic which is a combination of various metabolic disorders of organism. Nowadays biodiversity in gut microbiome and its impact on health is being studied very intensively. Gut microbiome has a main role as a reservoir of human genetics. Therefore its study is very topical. There are a lot of factual materials which indicate that gut undeniable influence on the immune system and intestinal barrier function, digestion, metabolism and systemic inflammation. It can be
rightfully claimed that microbes «in dialogue» with the whole body by way of sending us signals, which have to be researched and identified in the future.

References

1. Grundy S.M., Brewer H.B. Jr., Cleeman J.I., Smith S.C. Jr., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and
Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004. – 24: e13-e18.

2. Reaven GM: Banting lecture. Role of insulin resistance in human disease. Diabetes 1988. – 37: 1595-1607.

3. Kassi E., Pervanidou P., Kaltsas G., Chrousos G. Metabolic syndrome: definitions and controversies // BMC Medicine, 2011. – 9: 48.

4. http://www.heart.org

5. Ziramet P., Shaw J., Alberti G. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view // Diabetic medicine, 2003. – 20(9): 693-702.

6. Mamedov M, Suslonova N, Lisenkova, Tokareva Z. Metabolic syndrome prevalence in Russia: Prelimonary results of a cross-sectional population study. Diab Vase Dis res, 2007. – 4(1): 46-7.

7. https://www2.uef.fi/ru/nutritionepidemiologists/kihd

8. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and Management of the Metabolic
Syndrome. Circulation, 2005. – 112: 35–52.

9. Gu D, Reynolds K, Wu X, Jing Chen, Duan X, Reynolds R, Whelton P, He J; InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China // Lancet, 2005. – 365: 1398-405.

10. Jung-Nan Wei, Fung-Chang Sung, Chau-Ching Lin, Ruey-Shiung Lin, Chuan-Chi Chiang, Lee-Ming Chuang. National surveillance for type 2
diabetes mellitus in Taiwanese children // JAMA, 2003. – 290: 1345-50.

11. Ervin R.B. Prevalence of Metabolic Syndrome Among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003–2006 // National Health Statistics Repots, 2009.

12. Meigs J.B. Epidemiology of metabolic syndrome // Am. J Manag Care, 2002. – 8(11): 283-292.

13. Shalharova Zh.S. Metabolicheskyi sindrom: epidemiologiya, diagnostika, klinika i lechenie. – Almaty,2006.

14. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology // Proc Natl Acad Sci USA, 2005. – 102(31): 11070-5.

15. Everard A., Lazarevic V., Derrien M, Girard M., Muccioli G.G., Neyrinck A.M., Possemiers S., Holle AV., Francois P., Willem M. de Vos., Delzenne N., Schrenzel J., Cani P. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic
obese and diet-induced leptin-resistant mice // Diabetes, 2011. – 60(11): 2775-86.

16. Surawicz C.M., Brandt L.J., Binion D.G., Ananthakrishnan A.N., Curry S.R., Gilligan P.H., McFarland L., Mellow M., Zuckerbraun B. Guidelines
for diagnosis, treatment, and prevention of Clostridium difficile infections // Am J Gastroenterol, 2013. – 108(4): 478-98.

17. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., Deng Y., Blennerhassett P., Macri J., McCoy KD., Verdu EF., Collins SM. The intestinalmicrobiota affect central levels of brain-derived neurotropic
factor and behavior in mice // Gastroenterology, 2011. – 141(2): 599-609

18. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., Dallinga-Thie GM., Ackermans MT., Serlie MJ., Oozer R., Derrien M., Druesne A., Van Hylckama Vlieg JE., Bloks WW., Groen AK., Heilig HG., Zoetendal EG., Stroes ES., de Vos WM., Hoekstra JB., Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
// Gastroenterology, 2012. 143(4): 913-6.
How to Cite
KAKIMOVA, A. et al. Insights into the role of the gut microbiome in metabolic syndrome. International Journal of Biology and Chemistry, [S.l.], v. 8, n. 2, p. 36-39, feb. 2016. ISSN 2409-370X. Available at: <http://ijbch.kaznu.kz/index.php/kaznu/article/view/187>. Date accessed: 21 aug. 2017.
Section
Biology

Keywords

metabolic syndrome; metagenome; gut; microbiome; bacteria